We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
-0.32%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$257K
(-0.11%)
Cap. Flow
+$12.2M
Cap. Flow
% of AUM
5.15%
Top 10 Holdings %
Top 10 Hldgs %
35.07%
Holding
477
New
382
Increased
34
Reduced
30
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Home Depot
HD
|
+$3.72M |
| 2 |
Amazon
AMZN
|
+$3.54M |
| 3 |
Nike
NKE
|
+$3.34M |
| 4 |
Procter & Gamble
PG
|
+$3.32M |
| 5 |
Costco
COST
|
+$3.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$5.83M |
| 2 |
ZTO Express
ZTO
|
+$5.15M |
| 3 |
New Oriental
EDU
|
+$4.58M |
| 4 |
Li Auto
LI
|
+$4.42M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$3.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.45% |
| 2 | Consumer Discretionary | 23.79% |
| 3 | Healthcare | 23.76% |
| 4 | Communication Services | 3.6% |
| 5 | Consumer Staples | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $4K | ﹤0.01% |
+323
| New | +$3.68K |
|
302
Kodiak Sciences
KOD
$2.72B
| $4K | ﹤0.01% |
+487
| New | +$4.73K |
|
303
Karyopharm Therapeutics
KPTI
$46M
| $4K | ﹤0.01% |
+50
| New | +$3.73K |
|
304
Lexicon Pharmaceuticals
LXRX
$1.05B
| $4K | ﹤0.01% |
+1,719
| New | +$4.76K |
|
305
MeiraGTx Holdings
MGTX
$1.2B
| $4K | ﹤0.01% |
+418
| New | +$3.69K |
|
306
Precigen
PGEN
$2.45B
| $4K | ﹤0.01% |
+1,950
| New | +$4.11K |
|
307
Phathom Pharmaceuticals
PHAT
$742M
| $4K | ﹤0.01% |
+367
| New | +$3.5K |
|
308
Protagonist Therapeutics
PTGX
$9.84B
| $4K | ﹤0.01% |
+460
| New | +$4.35K |
|
309
Rallybio
RLYB
$88.1M
| $4K | ﹤0.01% |
+38
| New | +$3.38K |
|
310
Seer Inc
SEER
$118M
| $4K | ﹤0.01% |
+548
| New | +$5.32K |
|
311
Target
TGT
$69.9B
| $4K | ﹤0.01% |
+29
| New | +$4.64K |
|
|
ABCM
312
DELISTED
Abcam PLC
ABCM
| $4K | ﹤0.01% |
+242
| New | +$3.62K |
|
|
ICPT
313
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $4K | ﹤0.01% |
+279
| New | +$4.49K |
|
314
Absci
ABSI
$1.63B
| $3K | ﹤0.01% |
+869
| New | +$3.19K |
|
315
Arbutus Biopharma
ABUS
$908M
| $3K | ﹤0.01% |
+1,404
| New | +$3.31K |
|
|
AFMD
316
DELISTED
Affimed
AFMD
| $3K | ﹤0.01% |
+140
| New | +$3.89K |
|
|
ALLK
317
DELISTED
Allakos
ALLK
| $3K | ﹤0.01% |
+514
| New | +$2.15K |
|
318
Annexon
ANNX
$873M
| $3K | ﹤0.01% |
+446
| New | +$2.41K |
|
319
Atara Biotherapeutics
ATRA
$83.1M
| $3K | ﹤0.01% |
+35
| New | +$3.93K |
|
|
AVDL
320
DELISTED
Avadel Pharmaceuticals
AVDL
| $3K | ﹤0.01% |
+552
| New | +$3.04K |
|
321
BioAtla
BCAB
$5.61M
| $3K | ﹤0.01% |
+7
| New | +$2.29K |
|
322
Biomea Fusion
BMEA
$92.8M
| $3K | ﹤0.01% |
+275
| New | +$3.16K |
|
323
EyePoint Inc
EYPT
$1.17B
| $3K | ﹤0.01% |
+319
| New | +$2.96K |
|
|
GBIO
324
DELISTED
Generation Bio
GBIO
| $3K | ﹤0.01% |
+55
| New | +$3.44K |
|
325
HUTCHMED
HCM
$2.13B
| $3K | ﹤0.01% |
+359
| New | +$4.52K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q3 2022 Portfolio in Review
As of Q3 2022, China Universal Asset Management Company held 477 positions worth $238M, down 0.11% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
China Universal Asset Management Company deployed $12.2M of net new capital in Q3 2022, opening 382 new positions and adding to 34 existing holdings. Its largest new stake was Home Depot: 12,599 shares worth $3.48M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was JD.com, an estimated $5.83M trimmed.
- China Universal Asset Management Company's largest Q3 2022 buy was Home Depot: 12,599 shares worth $3.48M.
- China Universal Asset Management Company added most to Amazon in Q3 2022, an estimated $3.54M increase.
- China Universal Asset Management Company's biggest Q3 2022 reduction was JD.com, cutting an estimated $5.83M.
- China Universal Asset Management Company fully exited ZTO Express in Q3 2022, selling an estimated $5.15M.
- China Universal Asset Management Company's ten largest holdings make up 35% of its $238M portfolio in Q3 2022.
- China Universal Asset Management Company opened 382 new positions and closed 12 in Q3 2022.
- China Universal Asset Management Company's portfolio value fell 0.11% quarter-over-quarter to $238M.
Based on China Universal Asset Management Company's 13F filing for Q3 2022, filed 21 Oct 2022.